Bruns Ingmar 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 12, 2025
Insider Transaction Report
Form 4
Bruns Ingmar
Chief Medical Officer
Transactions
- Purchase
Common Stock
2025-02-06$2.28/sh+20,000$45,656→ 36,629 total
4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 12, 2025
Common Stock